Assessment of Thyroid Disease in Patients Who Underwent Surgical Treatment of Primary Hyperparathyroidism

Abstract

Purpose: In this study we aimed to evaluate thyroid pathologies in patients with primaryhyperparathyroidism who underwent surgery for parathyroidectomy.Methods: Patients who underwent parathyroidectomy for primary hyperparathyroidism betweenthe years of 2006-2012 were included in this retrospective study. Before and after surgery,hormonal and biochemical examinations of the patients and results of preoperative imagingstudies were recorded.Results: Of the patients included in the study, 86 were female and 12 were male. Preoperativemean serum calcium level was 12.25 ± 1.48 mg/dL (normal range 8.5-10.1 mg/dL), meanparathyroid hormone (PTH) level was 425.09 ± 440.47 pg/mL (normal range 11-65 pg/mL).The thyroid ultrasound records of 93 patients were available. Of these patients, 26 (28%) hadnormal ultrasound, 18 (19.4%) had solitary nodule, 43 (46.2%) had multinodular goiter and 4(4.3%) had thyroiditis (without nodule) and 2 (% 2.2) had solitary nodule with thyroiditis.Adenoma was detected by ultrasonography in 45.2 % of patients, and by scintigraphy in 72.7of patients. Parathyroidectomy and thyroidectomy were performed at the same time in 54 of 98patients (65.1%). Of these patients Seven (7.1%) had papillary thyroid cancer, 30 (30.6%) hadbenign multinodular goiter, 8 patients (8.2%) had benign solitary nodule, 2 patients (2%) hadlymphocytic thyroiditis, and 7 (7.1%) had normal thyroid tissue.Conclusion: Thyroid diseases are frequently encountered with primary hyperparathyroidism.Therefore, before performing parathyroidectomy with minimally invasive procedure, patientsmust be evaluated for thyroid disorders

Keywords

• Primary hyperparathyroidism,parathyroid surgery,thyroid carcinoma

PRİMER HİPERPARATİROİDİ NEDENİYLE OPERE EDİLEN VAKALARDA EŞLİK EDEN TİROİD PATOLOJİLERİNİN DEĞERLENDİRİLMESİ

Abstract

Amaç: Primer hiperparatiroidi (PHPT) nedeniyle paratirodektomi yapılan hastalarda eşlik edentiroid patolojilerinin değerlendirilmesi amaçlandı.Gereç ve Yöntem: Bu retrospektif çalışmaya 2006-2012 yılları arasında PHPT tanısı nedeniyleparatiroidektomi yapılan hastalar dahil edildi. Operasyon öncesi ve sonrası hastalarınbiyokimyasal ve hormonal tetkikleri, preoperatif görüntüleme tetkiklerinin sonuçları kaydedildi.Bulgular: Çalışmaya dahil edilen PHPT hastaların 86’sı kadın, 12’si erkekti. Hastalarınpreoperatif serum kalsiyumu ortalama 12.25 ± 1.48 mg/dL (8.5-10.1 mg/dL), paratiroit hormon(PTH) 425.09 ± 440.47 pg/mL (11-65 pg/mL) bulundu. Doksan sekiz hastanın 93’ünün tiroidultrason kayıtlarına ulaşıldı. Bu hastaların 26’sında (%28) tiroid ultrasonu normal, 18’inde(%19.4) soliter nodül, 43’ünde (%46.2) multinodüler guatr, 4’ünde (%4.3) tiroidit (nodülsüz),2’sinde (%2.2) soliter nodül ve tiroidit görünümü birlikte tespit edildi. Genel olarak hastaların%72’sinde tiroid patolojisi mevcuttu. Hastaların %45.2’sinde ultrasonda ve %72.7’sindeparatiroit sintigrafisinde paratiroit adenomu tespit edildi. Doksan sekiz hastanın 54’üne (%65.1)paratiroidektomi ile birlikte tiroidektomi de yapıldı. Yedi (%7.1) hastada papiller tiroid kanseri,30 hastada (%30.6) benign multinodüler guatr, 8 hastada (%8.2) benign soliter nodül, 2 hastada(%2) lenfositik tiroidit ve 7 hastada (%7.1) normal tiroid dokusu tespit edildi. Sonuç: Tiroid hastalıklarının PHPT ile birlikteliği sık görülebilmektedir. Bu nedenleparatiroidektominin minimal invaziv yöntemle yapılmasına karar vermeden önce hastalarmutlaka tiroid patolojisi açısından değerlendirilmelidir

Keywords

• Primer hiperparatiroidi,paratiroidektomi,tiroid kanseri

References

1. AACE/AAES Task Force on Primary Hyperparathyroidism. The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism. Endocr Pract. 2005;1(1):49-54.
2. Bentrem DJ, Peter Angelos P, Talamonti MS, Nayar R. Is Preoperative Investigation of the Thyroid Justified in Patients Undergoing Parathyroidectomy for Hyperparathyroidism Thyroid. 2002;1(2):1109-12.
3. Burmeister LA, Sandberg M, Carty SE, Watson CG. Thyroid carcinoma found at parathyroidectomy: association with primary, secondary, and tertiary hyperparathyroidism. Cancer. 1997;7(9):1611-16.
4. Linos DA, van Heerden JA, Edis AJ. Primary hyperparathyroidism and nonmedullary thyroid cancer. Am J Surg. 1982;14(3):301-3.
5. Krause UC, Friedrich JH, Olbricht T, Metz K. Association of primary hyperparathyroidism and non-medullary thyroid cancer. Eur J Surg. 1996;16(2):685-9.
6. Attie JN, Vardhan R. Association of hyperparathyroidism with nonmedullary thyroid carcinoma: review of 31 cases. Head Neck. 1993;1(5):20-3.
7. Gul K, Ozdemir D, Korukluoglu B. Preoperative and postoperative evaluation of thyroid disease in patients undergoing hyperparathyroidism. Endocr Pract. 2010;1(6):7-13. treatment of primary
8. Ogawa T, Kammori M, Tsuji E. Preoperative Evaluation of Thyroid Hyperparathyroidism. Thyroid. 2007;1(7):59-62. Patients with Primary

9. Kösem M, Algün E, Kotan C, Harman M, Oztürk M,et al. Coexistent thyroid pathologies and high rate of papillary cancer in patients with primary hyperparathyroidism: controversies about minimal invasive parathyroid surgery. Acta Chir Belg. 2004;10(4):568-71.
10. Lang W, Borrusch H, Bauer L. Occult carcinomas of the thyroid. Evaluation of 1020 sequential autopsies. Am J Clin Pathol. 1988;(90):72-6.
11. Martinez-Tello FJ, Martinez-Cabruja R, Fernandez-Martin J, Lasso-Oria C, Ballestin-Carcavilla C, et al. Occult carcinoma of the thyroid. A systematic autopsy study from Spain of two series performed with two different methods. Cancer. 1993;7(1):4022-9.
12. Vahle JL, Sato M, Long GG. Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1–34) for 2 years and relevance to human safety. Toxicol Pathol. 2002;(30):312–21.
13. Neer RM, Arnaud CD, Zanchetta JR. Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;3(44):1434–41.
14. Fedorak IJ, Salti G, Fulton N. Increased incidence of thyroid cancer in patients with primary hyperparathyroidism: A continuing dilemma. Am Surg. 1994;(60):427-31.
15. Aydın Y, Akbaba G, Berker D. Asemptomatik Primer Hiperparatiroidi Hastalarına Endokrinolojik Yaklaşım. Düzce Tıp Fakültesi Dergisi 2009; 11(2):43–46
16. Stephen AE, Chen KT, Milas M, Siperstein AE. The coming of age of radiation-induced hyperparathyroidism: evolving patterns of thyroid and parathyroid disease after head and neck irradiation. Surgery. 2004;13(6):1143–53.
17. De Jong SA, Demeter JG, Jarosz H, Lawrence AM, Paloyan E,et al. Thyroid carcinoma and hyperparathyroidism after radiation therapy for adolescent acne vulgaris. Surgery. 1991;1(10):691–5.
18. Isik S, Akbaba G, Berker D, Tutuncu YA, Ozuguz U, Aydin Y, Peksoy I, Guler S Thyroidrelated factors that influence preoperative localization of parathyroid adenoms Endocr Pract. 2012 Jan-Feb;18(1):26-33.
19. Földes I, Lévay A, Stotz G. Comparative scanning of thyroid nodules with technetium-99m pertechnetate and technetium- 99m methoxyisobutylisonitrile. Eur J Nucl Med. 1993;(20):330-3.